metsera novo nordisk - Search News

Pfizer hits Novo Nordisk and Metsera

Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer

Novo Nordisk is raising the stakes in its push to outbid rival Pfizer and acquire the development-stage drugmaker Metsera.

· 9h · on MSN

Novo Nordisk and Pfizer Sweeten Their Offers for Weight-Loss Drug Startup Metsera

· 6h · on MSN

Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera

· 20h

Pfizer plays hardball in weight-loss drug fight

Pfizer has filed a second lawsuit against Novo Nordisk and obesity drug start-up Metsera.

· 12h

Novo Nordisk AS (OCSE:NOVO B) Q3 2025: Everything You Need To Know Ahead Of Earnings

· 1d

Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuit

Devdiscourse

Legal Showdown: Pfizer and Novo Nordisk Clash Over Metsera in Fierce Obesity Drug Battle

Pfizer and Novo Nordisk are in a heated legal and bidding war over Metsera, an obesity drug developer. Novo's $10 billion bid challenges Pfizer's prior deal with Metsera. Pfizer has sued to stop the process,

5don MSN

Metsera says Novo Nordisk’s $9B buyout offer “superior”; Pfizer calls bid “illusory”

Novo Nordisk ups its bid to acquire Metsera, intensifying the obesity drug market race and challenging Pfizer.

Vice Chancellor Zurn Rejects TRO on Novo Nordisk-Metsera Deal During Active Bidding Process

Pfizer has requested a temporary restraining order to keep Metsera from breaking its contract with Pfizer to take a deal with Novo Nordisk.